947523-45-7Relevant articles and documents
Discovery of a Tetrahydrobenzisoxazole Series of γ-Secretase Modulators
Zhao, Zhiqiang,Pissarnitski, Dmitri A.,Huang, Xianhai,Palani, Anandan,Zhu, Zhaoning,Greenlee, William J.,Hyde, Lynn A.,Song, Lixin,Terracina, Giuseppe,Zhang, Lili,Parker, Eric M.
, p. 1002 - 1006 (2017)
The design and synthesis of a new series of tetrahydrobenzisoxazoles as modulators of γ-secretase activity and their structure-activity relationship (SAR) will be detailed. Several compounds are active γ-secretase modulators (GSMs) with good to excellent selectivity for the reduction of Aβ42 in the cellular assay. Compound 14a was tested in vivo in a nontransgenic rat model and was found to significantly reduce Aβ42 in the CNS compartment compared to vehicle-treated animals (up to 58% reduction of cerebrospinal fluid Aβ42 as measured 3 h after an acute oral dosing at 30 mg/kg).